Summary
This case study details the challenges faced by a clinical-stage precision medicine company in managing their validation processes. The company relied on a traditional validation approach using digital file storage and pen and paper, which hindered their ability to ensure Good Practice (GxP) compliance across their digital ecosystem. As software releases and regulatory changes increased, the company accumulated validation debt, leading to higher costs and risk exposure. To address these issues, the company transitioned from computer software validation (CSV) to computer software assurance (CSA) by implementing Sware's Res_Q validation platform. This new approach streamlined their validation processes through automation and reduced reliance on manual methods. The case study outlines the outcomes of this transition, including improved efficiency, reduced validation times, and enhanced risk management. The company now manages over 30 internal and external releases per quarter with greater assurance and fewer dedicated resources.
